MEMORIA CIENTIFICA 2021

Servicio de Dermatología.

Hospital Universitario San Cecilio

 

PUBLICACIONES

 

Dermatología General

 

  1. Pérez-López I, Moyano-Bueno D, Ruiz-Villaverde R. Bullous pemphigoid and COVID-19 vaccine. Med Clin (Engl Ed). 2021 Nov 26;157(10):e333-e334.
  2. De La Torre Gomar FJ, Gimeno Castillo J, García Río I. sQuiz your knowledge: Painful erythematous papulonodular lesions on the trunk. Eur J Dermatol. 2021 Apr 1;31(2):294-295.
  3. Gimeno Castillo J, de la Torre Gomar FJ, Saenz Aguirre A. Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir. Med Clin (Engl Ed). 2021 May 7;156(9):468-469.
  4. Gimeno Castillo J, de la Torre Gomar FJ, Saenz Aguirre A. Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir. Med Clin (Barc). 2021 May;156(9):468-469. English, Spanish.
  5. Pérez-López I, Moyano-Bueno D, Ruiz-Villaverde R. Bullous pemphigoid and COVID-19 vaccine. Med Clin (Barc). 2021 Nov 26;157(10):e333-e334.
  6. Pérez-López I, Gil-Villalba A, Ruiz-Villaverde R. Perniosis-like lesions after vaccination with mRNA against COVID-19. Med Clin (Barc). 2021 Jun 16:S0025-7753(21)00324-9.
  7. Linares-Gonzalez L, Rodenas-Herranz T, Campos F, Ruiz-Villaverde R, Carriel V. Basic Quality Controls Used in Skin Tissue Engineering. Life (Basel). 2021 Sep 30;11(10):1033.
  8. Moreno-Suarez FG, Ayén-Rodriguez A, Ruiz-Villaverde R. sQUIZ your Knowledge! Erythematous pectoral plaques and a fast-growing cervical mass. Eur J Dermatol. 2021 Aug 1;31(4):591-593.
  9. Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Ruiz-Villaverde R, Lozano-Lozano M. Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment. Int J Dermatol. 2021 Oct 11. doi: 10.1111/ijd.15938.
  10. Linares-Gonzalez L, Rodenas-Herranz T, Campos F, Ruiz-Villaverde R, Carriel V. Basic Quality Controls Used in Skin Tissue Engineering. Life (Basel). 2021 Sep 30;11(10):1033.
  11. Moreno-Suarez FG, Ayén-Rodriguez A, Ruiz-Villaverde R. sQUIZ your Knowledge! Erythematous pectoral plaques and a fast-growing cervical mass. Eur J Dermatol. 2021 Aug 1;31(4):591-593.
  12. Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Ruiz-Villaverde R, Lozano-Lozano M. Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment. Int J Dermatol. 2021 Oct 11. doi: 10.1111/ijd.15938.
  13. Pereyra-Rodriguez JJ, Dominguez-Cruz J, Armario-Hita JC, Ruiz-Villaverde R. 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain. An Bras Dermatol. 2021 Nov-Dec;96(6):787-790.
  14. Pereyra-Rodriguez JJ, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Ruiz-Villaverde R, Vilar-Palomo S, Armario-Hita JC. Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis. Life (Basel). 2021 Sep 6;11(9):927.
  15. Navarro-Triviño FJ, Vega-Castillo JJ, Llamas-Molina JM, Ruiz-Villaverde R. Refractory Head and Neck atopic dermatitis pattern treated with Dupilumab: Allergic contact dermatitis caused by decyl glucoside. Should surfactants be patched? Australas J Dermatol. 2021 Nov;62(4):509-511.
  16. Llamas-Molina JM, Carrero Castaño A, Ruiz-Villaverde R. sQuiz your knowledge! Erythemathous-violaceous painful nodules on the limbs and ankle arthritis in a patient with acute pancreatitis. Eur J Dermatol. 2021 Jun 1;31(3):440-442.
  17. Llamas-Molina JM, Carrero Castaño A, Ruiz-Villaverde R. sQUIZ your Knowledge! A patch of blue-grey papules on the shoulder of an adolescent patient. Eur J Dermatol. 2021 Jun 1;31(3):438-439.
  18. Català A, Muñoz-Santos C, Galván-Casas C, Roncero Riesco M, Revilla Nebreda D, Solá-Truyols A, Giavedoni P, Llamas-Velasco M, González-Cruz C, Cubiró X, Ruíz-Villaverde R, Gómez-Armayones S, Gil Mateo MP, Pesqué D, Marcantonio O, Fernández-Nieto D, Romaní J, Iglesias Pena N, Carnero Gonzalez L, Tercedor- Sanchez J, Carretero G, Masat-Ticó T, Rodríguez-Jiménez P, Gimenez-Arnau AM, Utrera-Busquets M, Vargas Laguna E, Angulo Menéndez AG, San Juan Lasser E, Iglesias-Sancho M, Alonso Naranjo L, Hiltun I, Cutillas Marco E, Polimon Olabarrieta I, Marinero Escobedo S, García-Navarro X, Calderón Gutiérrez MJ, Baeza-Hernández G, Bou Camps L, Toledo-Pastrana T, Guilabert A. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2021 Jul 13:10.1111/bjd.20639.
  19. Navarro-Triviño FJ, Vega-Castillo JJ, Ruiz-Villaverde R. Nail changes successfully treated with dupilumab in a patient with severe atopic dermatitis. Australas J Dermatol. 2021 Aug;62(3):e468-e469.
  20. Ayén-Rodriguez A, Llamas-Molina JM, Cabrerizo-Carvajal AM, Leon-Lopez FJ, Ruiz-Villaverde R. Teledermatología en el Área Sanitaria Centro Oeste de Granada: desde atención primaria a especializada [Teledermatology in the Health Center West Area of Granada: From primary to specialized care]. Semergen. 2021 May-Jun;47(4):224-229.
  21. Navarro-Triviño F, Ródenas-Herranz T, Linares-Gonzalez L, Ruiz-Villaverde R. Disseminated Necrobiotic Xanthogranuloma. Med Clin (Barc). 2021 Nov 26;157(10):505.
  22. Ródenas-Herranz T, Navarro-Triviño FJ, Ruiz-Villaverde R. sQUIZ your knowledge! Koebnerization in end-stage renal disease. Eur J Dermatol. 2021 Feb 1;31(1):138-139.
  23. Ayen-Rodriguez A, Llamas-Molina JM, Ruiz-Villaverde R. sQUIZ your Knowledge! Widespread erythematous non-follicular papules and Epstein-Barr virus infection. Eur J Dermatol. 2021 Feb 1;31(1):125-126.
  24. Ruiz-Villaverde R, Faro-Miguez N, Sánchez-Cano D, Martín-Pérez AJ. Sarcoma de Kaposi clásico: más allá de la piel [Classic Kaposi sarcoma: Beyond the skin]. Rev Esp Geriatr Gerontol. 2021 Nov-Dec;56(6):371-372.
  25. Ruiz-Villaverde R, Rueda-Villafranca B, Galvez-Moreno M. Progressive Asymptomatic Thickening of a Lip. Actas Dermosifiliogr (Engl Ed). 2021 Mar 3:S0001-7310(21)00102-2.
  26. Ayén-Rodriguez A, Benavente-Fernandez A, Sánchez-Cano D, Ruiz-Villaverde R. Hematuria, an unusual presentation of metastatic malignant melanoma. Int J Dermatol. 2021 Aug;60(8):e302
  27. Garrido-Colmenero C, Martínez-Peinado CM, Galán-Gutiérrez M, Barranco-Millán V, Ruiz-Villaverde R. Successful response of vulvar lichen sclerosus with NB- UVB. Dermatol Ther. 2021 Mar;34(2):e14801
  28. Ruiz-Villaverde R, Rueda-Villafranca B, Ruiz-Carrascosa JC. Bruise-like Spots Appearing Progressively on the Face and Back. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):447-448.
  29. Ródenas-Herranz T, Linares-González L, Ruiz-Villaverde R. RF- IgG4-Related Disease 4 Years On. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):461-462.
  30. Linares-González L, Ródenas-Herranz T, Espelt-Otero JL, Ruiz-Villaverde R. Buschke Sclerederma Refractory to Conventional Treatment: Response to UV-A1 Phototherapy. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):466-468.
  31. Ruiz-Villaverde R, García-Lara GM, Llamas-Molina JM, Ayén-Rodriguez A. A skin ulcer may be a clue to rule out the Blue Whale Challenge. Int J Dermatol. 2021 May;60(5):e184-e185.
  32. Vega-Castillo JJ, Sáenz-Guirado S, Ruiz-Villaverde R. Villar Nodule: An Umbilical Nodule Associated With a Good Prognosis. Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):178.
  33. Ródenas-Herranz T, Ayén-Rodriguez A, Llamas-Molina JM, Ruiz-Villaverde R. Penfigoide ampolloso sobre herida quirúrgica. ¿Una complicación emergente en el anciano? [Bullous pemphigoid over a surgical wound. An emerging complication in the elderly?]. Aten Primaria. 2021 Jan;53(1):104-106.
  34. Navarro-Triviño FJ, Llamas-Molina JM, Ayen-Rodriguez A, Cancela-Díez B, Ruiz-Villaverde R. Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient. Eur J Hosp Pharm. 2021 Nov;28(6):350-352.
  35. Llamas-Molina JM, Ayén-Rodriguez A, Ruiz-Villaverde R. Hemangioma hemosiderótico en diana: una dermoscopia fácilmente identificable [Haemosiderotic hemangioma on target: An easily identifiable dermoscopy]. Semergen. 2021 Mar;47(2):e15-e16.
  36. Pérez-López I, Ródenas-Herranz T, Ruiz-Villaverde R. Hereditary leiomyomatosis associated with renal cell carcinoma. Med Clin (Barc). 2021 Sep 24;157(6):307.
  37. Pereyra-Rodriguez JJ, Domínguez-Cruz J, Ruiz-Villaverde R, Silvestre JF, Galán M, Curto L, Figueras I, Serra-Baldrich E, Armario-Hita JC. Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study. Br J Dermatol. 2021 Jan;184(1):175-176.
  38. Linares-González L, Ródenas-Herranz T, Vera-Álvarez S, Ruiz-Villaverde R. Massive painful parietal necrosis. Med Clin (Barc). 2021 Apr 23;156(8):418.
  39. Navarro-Triviño FJ, Moreno-Higueras M. Keratoderma and dental involvement. Rev Clin Esp (Barc). 2021 Jul 27:S2254-8874(21)00121-1.
  40. Navarro-Triviño FJ, Lucas-Collado N, Salvatierra-Ossorio J. Erupción fototóxica inducida por leflunomida en una paciente con lupus eritematoso sistémico. Actas Dermosifiliogr (Engl Ed). 2021 May 21:S0001-7310(21)00193
  41. Navarro-Triviño FJ. Asymptomatic eruptive facial papules. Rev Clin Esp (Barc). 2021 Jan;221(1):66-67.
  42. Navarro-Triviño FJ, Sánchez-López J. Rheumatoid Neutrophilic Bullous Dermatosis. Actas Dermosifiliogr. 2021 Jul;112 Suppl 1:6.
  43. Llamas-Molina JM, Linares-González L, Navarro-Triviño FJ. Erupción lineal en tronco posterior, ¿es o no es un herpes zóster? [Linear eruption on the back, is it or is it not a herpes zoster?]. Semergen. 2021 Oct;47(7):e53-e54.
  44. Linares-González L, Ródenas-Herranz T, Navarro-Triviño FJ. Verano, sol y guacamole casero, ¿qué podía salir mal? [Summer, sun and homemade guacamole… what could go wrong?]. Semergen. 2021 Jul-Aug;47(5):e39-e40.
  45. Navarro-Triviño FJ. Skin Reactions to Glucose Sensors: Present and Future. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):389-391.
  46. Navarro Triviño FJ, Linares González L, Rodenas Herranz T. A «Cesarean Scar» - With No C-Section! Actas Dermosifiliogr (Engl Ed). 2021 Apr;112(4):365.

 

Unidad de Terapia Fotodinamica

 

1. Sáenz-Guirado S, Cuenca-Barrales C, Vega-Castillo J, Linares-Gonzalez L, Ródenas-Herranz T, Molina-Leyva A, Ruiz-Villaverde R. Combined versus conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study. Photodermatol Photoimmunol Photomed. 2021 Nov 12. doi: 10.1111/phpp.12753.

2. Navarro-Triviño FJ, Ayén-Rodríguez Á, Llamas-Molina JM, Saenz-Guirado S, Ruiz-Villaverde R. Treatment of superficial basal cell carcinoma with 7.8% 5-aminolaevulinic acid nanoemulsion-based gel (BF-200 ALA) and photodynamic therapy: Results in clinical practice in a tertiary hospital. Dermatol Ther. 2021 Jan;34(1):e14558.

 

Unidad de Dermatologia Pediátrica

 

1.Ruiz-Villaverde R, Navarrro-Triviño FJ, Galvez-Moreno M. What the pyogenic granuloma hides. J Paediatr Child Health. 2021 Jul;57(7):1140.

 

Unidad de Melanoma y Oncologia Cutánea

 

  1. Conde-Ferreirós A, Moyano-Bueno D, Santos-Briz Á, Revelles-Peñas L, Revilla-Nebreda D, Becerril-Andrés S, Román-Curto C, Cañueto J. Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case-control study. J Cutan Pathol. 2021 Aug 7. doi: 10.1111/cup.14116.
  2. Tejera-Vaquerizo A, Paradela S, Toll A, Santos-Juanes J, Jaka A, López A, Cañueto J, Bernal À, Villegas-Romero I, Ferrándiz-Pulido C, Perandones H, Moreno-Ramírez D, Domínguez-Mahamud C, Salido-Vallejo R, Sanmartin O, Almazán-Fernández FM, Rodríguez-Jiménez P, Bañuls J, Podlipnik S, Sandoval-Clavijo A, Boada A, García-Bracamonte B, Palencia S, Revilla-Nevreda D, Reola-Ramírez E, Del Carmen Gómez-Mateo M, Linares-Barrios M, Jiménez-Gallo D, González-Cruz C, Samaniego E, Navedo-de Las Heras M, Taberner R, Ródenas-Herranz T, García-Donoso C, Puig S, Nagore E. Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol. 2021 Aug 25;101(8):adv00525.
  3. Palacios-Ferrer JL, García-Ortega MB, Gallardo-Gómez M, García MÁ, Díaz C, Boulaiz H, Valdivia J, Jurado JM, Almazan-Fernandez FM, Arias-Santiago S, Amezcua V, Peinado H, Vicente F, Pérez Del Palacio J, Marchal JA. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma. Mol Oncol. 2021 Feb;15(2):407-428.
  4. Wang X, Almazan F, Montoyo-Pujol YG, Martin-Casares A, Martin A, Cabrera T, López-Nevot MA. HLA-DRB1<i>∗</i>16:01 and HLA-DQB1<i>∗</i>05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma. J Oncol. 2021 Sep 30;2021:3801143. doi: 10.1155/2021/3801143.
  5. Wang X, Montoyo-Pujol YG, Bermudez S, Corpas G, Martin A, Almazan F, Cabrera T, López-Nevot MA. Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis. J Oncol. 2021 Jan 28;2021:6610769.
  6. Montoyo-Pujol YG, Wang X, Bermúdez-Sánchez S, Martin A, Almazan F, López-Nevot MÁ. Measurement of 45 cytokine, chemokine and growth factors in established cell culture supernatants and autologous serum from advanced melanoma patients. Carcinogenesis. 2021 May 28;42(5):714-723.

Unidad de Fototerapia

 

1.Linares-González L, Ródenas-Herranz T, Espelt-Otero JL, Ruiz-Villaverde R. Buschke Sclerederma Refractory to Conventional Treatment: Response to UV-A1 Phototherapy. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):466-468.

 

Unidad de Inmunoalergia

 

1. Navarro-Triviño FJ, Vega-Castillo JJ, Llamas-Molina JM, Ruiz-Villaverde R. Refractory Head and Neck atopic dermatitis pattern treated with Dupilumab: Allergic contact dermatitis caused by decyl glucoside. Should surfactants be patched? Australas J Dermatol. 2021 Nov;62(4):509-511.

2. Navarro-Triviño FJ, Ruiz-Villaverde R. Genital allergic contact dermatitis caused by cocamide DEA. Contact Dermatitis. 2021 Dec;85(6):701-703.

3. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis caused by Benjuí extract in a natural cosmetic cream. Contact Dermatitis. 2021 Dec;85(6):698-699.

4. Gatica-Ortega ME, Mowitz M, Pastor-Nieto MA, Navarro-Triviño FJ, Fernández- Redondo V, Hernández-Cano N, Borrego L, Gómez-de-la-Fuente E, Torralba M, Svedman C, Giménez-Arnau A. Contact dermatitis from glucose sensors in Spain: A multicentric approach. Contact Dermatitis. 2021 Nov;85(5):554-562.

5. Navarro-Triviño FJ. Occupational allergic contact dermatitis caused by thiourea in a jewelry cleaner. Contact Dermatitis. 2021 Nov;85(5):591-593.

6. Navarro-Triviño FJ, Lucas-Collado N, Salvatierra-Ossorio J. Erupción fototóxica inducida por leflunomida en una paciente con lupus eritematoso sistémico. Actas Dermosifiliogr (Engl Ed). 2021 May 21:S0001-7310(21)00193-9.

7. Navarro-Triviño FJ, Vega-Castillo JJ, de Cádiz VAC, Ruiz-Villaverde R. Generalized allergic contact dermatitis after periostomal dermatitis caused by Stomahesive paste (ConvaTec). Contact Dermatitis. 2021 Oct;85(4):479-481.

8. Navarro-Triviño FJ, Cassini Gómez de Cádiz VA, Ruiz-Villaverde R. Allergic connubial contact dermatitis caused by molybdenum from fiberglass. Int J Dermatol. 2021 Mar;60(3):e88-e90

9. Navarro-Triviño FJ, Linares-González L, Llamas-Molina JM, Ruiz-Villaverde R. Airborne allergic contact dermatitis caused by spirotetramat (Movento 150®). Contact Dermatitis. 2021 Jul;85(1):99-100.

10: Navarro Triviño FJ, Linares-González L, Ródenas-Herranz T, Llamas-Molina JM, Ruiz-Villaverde R. Acute localized exanthematous pustulosis (ALEP) induced by iomeprol (Iomeron 350): A diagnostic challenge. Contact Dermatitis. 2021 Jul;85(1):95-97.

11. Navarro-Triviño FJ, Cuenca-Manteca J, Ruiz-Villaverde R. Allergic Contact Dermatitis to VenaSeal After Chronic Venous Insufficiency Treatment Mimics Phlebitis. Dermatitis. 2021 Jul-Aug 01;32(4):e67-e68. doi:

12. Navarro-Triviño FJ, Jadczak P, Llamas-Molina JM, Ruiz-Villaverde R. Lichenoid contact dermatitis caused by Morus nigra L. Contact Dermatitis. 2021 Jun;84(6):484-486.

13. Navarro-Triviño FJ, Linares-González L, Ayén-Rodríguez Á, Ruiz-Villaverde R. Allergic contact dermatitis caused by tocopheryl nicotinate. Contact Dermatitis. 2021 Jun;84(6):479-480.

14. Navarro-Triviño FJ. Skin Reactions to Glucose Sensors: Present and Future. Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):389-391.

15. Navarro-Triviño FJ, Ruiz-Villaverde R. Periocular allergic contact dermatitis caused by brinzolamide. Contact Dermatitis. 2021 Apr;84(4):274-276.

16. Navarro-Triviño FJ, Naranjo-Diaz MJ, Ruiz-Villaverde R. Cutaneous lymphoid hyperplasia caused by cosmetic lip tattoo successfully treated with tacrolimus 0.1% ointment. Contact Dermatitis. 2021 Apr;84(4):270-272.

17. Navarro-Triviño FJ, Ruiz-Villaverde R. Photoallergic contact cheilitis from methylchloroisothiazolinone/methylisothiazolinone: Where is the culprit product?. Contact Dermatitis. 2021 Mar;84(3):199-200.

18. Navarro-Triviño FJ, Ruiz-Villaverde R. Phototoxic eruption caused by enzalutamide (Xtandi). Contact Dermatitis. 2021 Jan;84(1):64-65.

19. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis to eyeglass frame nosepiece caused by tetraethylthiuram disulphide and resorcinol monobenzoate. Int J Dermatol. 2021 Apr;60(4):e156-e158.

20. Navarro-Triviño FJ, Ruiz-Villaverde R. Allergic contact dermatitis caused by surgical mesh after umbilical hernia surgery. Contact Dermatitis. 2021 Jan;84(1):60-62.

21. Navarro-Triviño FJ, Jadczak P, Ruiz-Villaverde R. Allergic contact dermatitis caused by Lavandula angustifolia and cross-reaction with Citrus bergamia essential oils in an aromatherapist. Int J Dermatol. 2021 Feb;60(2):241-243.

22. De la Torre Gomar FJ, Heras González S, González Pérez R. Are Patch Test Results Usually Relevant in Patients With Burning Mouth Syndrome? Actas Dermosifiliogr (Engl Ed). 2021 Jan;112(1):88-89.

 

Unidad de Psoriasis

 

1. Aguayo-Carreras P, Ruiz-Carrascosa JC, Ruiz-Villaverde R, Molina-Leyva A. Four years stability of type D personality in patients with moderate to severe psoriasis and its implications for psychological impairment. An Bras Dermatol. 2021 Sep-Oct;96(5):558-564.

2. Vidal S, Puig L, Carrascosa-Carrillo JM, González-Cantero Á, Ruiz-Carrascosa JC, Velasco-Pastor AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int J Mol Sci. 2021 Jun 23;22(13):6740.

3. Ruiz-Villaverde R, Ruiz-Carrascosa JC, Galán-Gutierrez M, Armario-Hita JC. Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice. Dermatol Ther. 2021 Jan;34(1):e14711.

4. Del Alcázar E, López-Ferrer A, Martínez-Doménech Á, Ruiz-Villaverde R, Del Mar Llamas-Velasco M, Rocamora V, Julià M, Notario J, Rodríguez Fernández-Freire L, Sahuquillo-Torralba A, Vidal D, Rivera R, Carretero G, Mateu A, de la Cueva P, Carrascosa YJM. Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. Dermatol Ther. 2021 Nov 24:e15231.

5. Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Pérez-Gil A, Galán-Gutiérrez M. Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series. Int J Dermatol. 2021 Nov 3. doi: 10.1111/ijd.15784.

6. Galán-Gutierrez M, Rodriguez-Fernandez Freire L, Ruiz-Villaverde R. Tildrakizumab: short-term efficacy and safety in real clinical practice. Int J Dermatol. 2021 Oct 11.

7. Salgado-Boquete L, Carrascosa JM, Llamas-Velasco M, Ruiz-Villaverde R, de la Cueva P, Belinchón I. A New Classification of the Severity of Psoriasis: What's Moderate Psoriasis? Life (Basel). 2021 Jun 29;11(7):627.

8. Navarro-Triviño FJ, Lozano-Lozano M, Ruiz-Villaverde R. Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use. Dermatol Pract Concept. 2021 May 20;11(3):e2021056.

9. Herranz P, Trasobares L, Mateu A, Martínez E, Ruiz-Villaverde R, Baniandrés O, Mataix Díaz J, Jiménez-Gómez N, Serra M, Ruiz Genao DP, Rivera N, Tercedor- Sánchez J, Garcia C, Cordey M, Herrera-Acosta E. Characterization and Outcomes in Patients Treated With Apremilast in Routine Clinical Practice in Spain: Results From the APPRECIATE Study. Actas Dermosifiliogr (Engl Ed). 2021 May 27:S0001-7310(21)00202-7.

10. Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Pérez-Gil A, Galán-Gutiérrez M. Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice. Dermatol Ther. 2021 Mar;34(2):e14798.

11. Ruiz-Villaverde R, Ruiz-Carrascosa JC, Galán-Gutierrez M, Armario-Hita JC. Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice. Dermatol Ther. 2021 Jan;34(1):e14711.

12. Ruiz-Villaverde R, Rodríguez Fernández-Freire L, Galán-Gutiérrez M, Armario- Hita JC, Martinez-Pilar L. Secukinumab: Drug Survival in Clinical Practice Settings. Actas Dermosifiliogr (Engl Ed). 2021 Apr;112(4):361-364.

13. Belinchón I, Velasco M, Ara-Martín M, Armesto Alonso S, Baniandrés Rodríguez O, Ferrándiz Pulido L, García-Bustinduy M, Martínez-López JA, Martínez Sánchez N, Pérez Ferriols A, Pérez Pascual E, Rivera Díaz R, Ruiz-Villaverde R, Taberner Ferrer R, Vicente Villa A, Carrascosa JM. Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement. Actas Dermosifiliogr (Engl Ed). 2021 Mar;112(3):225-241.

14. Ródenas-Herranz T, Linares-González L, Carpena-Martínez I, Pérez-Ramos M, Ruiz-Villaverde R. Cutaneous leishmaniasis induced by TNF-α blockers: a diagnostic challenge. Int J Dermatol. 2021 Mar;60(3):e101-e103.

15. Ruiz-Villaverde R, Galán-Gutierrez M. Biosimilars in psoriasis: what should your positioning be? Expert Opin Biol Ther. 2021 Jan;21(1):81-86.

 

Unidad de Tricología

 

1. Porriño-Bustamante ML, Fernández-Pugnaire MA, Arias-Santiago S. Frontal Fibrosing Alopecia: A Review. J Clin Med. 2021 Apr 21;10(9):1805.

2.Porriño-Bustamante ML, Lázaro-Ochaita P, Fernández-Pugnaire MA. Frontal fibrosing alopecia in a woman with vulvar erosive lichen planus. Med Clin (Barc). 2021 Dec 10;157(11):e341-e342.

3. Porriño-Bustamante ML, Fernández-Pugnaire MA, Castellote-Caballero L, Arias- Santiago S. Colour Doppler ultrasound study in patients with frontal fibrosing alopecia. Skin Res Technol. 2021 Sep;27(5):709-714.

 

ESTUDIOS OBSERVACIONALES

 

Unidad de Terapia Fotodinámica

 

Terapia Fotodinámica convencional vs Terapia Fotodinámica Luz de Día + Terapia Fotodinámica Convencional

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA. Soledad Saénz Guirado

 

Unidad de Melanomas/Oncología cutánea

 

Sintomatología asociada a la BSGC

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Francisco Almazán Fernández

 

Crecimiento tumoral Carcinoma Epidermoide de alto riesgo en pandemia COVID-19

Promotor: Servicio de Dermatología. Globalderm.

IP Antonio Tejera Vaquerizo

FEA: Francisco Almazán Fernández y EIR: Teresa Ródenas Herranz

Publicado: Tejera-Vaquerizo A, Paradela S, Toll A, Santos-Juanes J, Jaka A, López A, Cañueto J, Bernal À, Villegas-Romero I, Fernández-Pulido C, Perandones H, Moreno-Ramírez D, Domínguez-Mahamud C, Salido-Vallejo R, Sanmartin O, Almazán-Fernández FM, Rodríguez-Jiménez P, Bañuls J, Podlipnik S, Sandoval-Clavijo A, Boada A, García-Bracamonte B, Palencia S, Revilla-Nevreda D, Reola-Ramírez E, Del Carmen Gómez-Mateo M, Linares-Barrios M, Jiménez-Gallo D, González-Cruz C, Samaniego E, Navedo-de Las Heras M, Taberner R, Ródenas-Herranz T, García-Donoso C, Puig S, Nagore E. Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol. 2021 Aug 25;101(8):adv00525. doi: 10.2340/00015555-3890. PMID: 34396424.

 

Conservative nodal surgery (node-picking) of patients with stage III melanoma with low-burden of nodal disease (MELCONSURG MULTICENTRE COHORT)

Promotor: Hospital Universitario Virgen Macarena.

IP David Moreno Ramirez

FEA. Francisco Almazan Fernandez y Ricardo Ruiz Villaverde

 

Dermatología General

 

Caracterización histología y molecular de la matriz extracelular en la AAF. Estudio prospectivo, abierto, no controlado

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Ricardo Ruiz Villaverde y Francisco J Navarro Triviño

 

A prospective observational study of adult patients receiving Dupixent for atopic dermatitis

Protocol Number: OBS15990 / GLOBOSTAD

Investigador principal: Ricardo Ruiz Villaverde

 

Reacciones cutáneas tras la administración de vacunas frente a SARS-COV-2

Codi CEIm: 20212011 Codi Promotor: NA Versió i data: V3 de 20 de gener de 2021

IP: Carlos Muñoz Santos. Alba Catalá Gonzalo y Cristina Galvan Casas

Investigador principal local: Ricardo Ruiz Villaverde

Publicado: Català A, Muñoz-Santos C, Galván-Casas C, Roncero Riesco M, Revilla Nebreda D, Solá-Truyols A, Giavedoni P, Llamas-Velasco M, González-Cruz C, Cubiró X, Ruíz-Villaverde R, Gómez-Armayones S, Gil Mateo MP, Pesqué D, Marcantonio O, Fernández-Nieto D, Romaní J, Iglesias Pena N, Carnero Gonzalez L, Tercedor-Sanchez J, Carretero G, Masat-Ticó T, Rodríguez-Jiménez P, Gimenez-Arnau AM, Utrera-Busquets M, Vargas Laguna E, Angulo Menéndez AG, San Juan Lasser E, Iglesias-Sancho M, Alonso Naranjo L, Hiltun I, Cutillas Marco E, Polimon Olabarrieta I, Marinero Escobedo S, García-Navarro X, Calderón Gutiérrez MJ, Baeza-Hernández G, Bou Camps L, Toledo-Pastrana T, Guilabert A. Cutaneous reactions after SARS-COV-2 vaccination: A cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20639.

 

Estudio Observacional transversal para evaluar el impacto de la urticaria crónica desde la perspectiva del paciente. Encuesta Atlas de Urticaria crónica

Promotor: Novartis

Investigador principal local: Ricardo Ruiz Villaverde

Completado

 

Percepción de la mujer con dermatitis atópica moderada-grave en la planificación familiar

Promotor: Grupo andaluz de Dermatitis atópica

Investigador Principal: Sara Alcántara Luna. Hospital Juan Ramon Jiménez

IP local: Ricardo Ruiz Villaverde

 

Frecuencia y factores asociados a la presencia de reacciones dermatológicas tras la vacunación de COVID-19 (Comirnaty)® en profesionales sanitarios.

Promotor: Hospital Universitario San Cecilio

Investigador principal: Ricardo Ruiz Villaverde – Servicio de Dermatología, Hospital Universitario Clínico San Cecilio.

 

Unidad de Psoriasis

 

Estudio retrospectivo multicéntrico de práctica clínica habitual en pacientes con psoriasis moderada a grave tratados con Guselkumab. Estudio Spring

Código de protocolo del promotor: JAN-GUS-2019-02

Investigador principal: José Carlos Ruiz Carrascosa

Completado

 

Tratamiento de la psoriasis localizada en cuero cabelludo con Enstilar® espuma cutánea (Cal / BD).

Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio

FEA: Ricardo Ruiz Villaverde y Francisco J Navarro Triviño

 

Aplicación de Inteligencia artificial en la Cuantificación de la severidad de la psoriasis, IMAPSORS

Promotor: Servicio de Dermatología. Hospital de Manises, Valencia

Investigador principal: Antonio Martorell Calatayud

Investigador principal local: Ricardo Ruiz Villaverde

Completado

 

Search for pharmacogenetic biomarkers of anti-IL17R and anti-IL23 drug response in psoriasis patients

Promotor: Servicio de Dermatología. Hospital de la Princesa, Madrid

Investigador Principal: Esteban Daudén Tello

IP local. Ricardo Ruiz Villaverde

 

A multicenter, prospective observational RWE study to assess Patient-reported wellbeing using tildrakizumab in a live setting – POSITIVE Study

Promotor: Almirall

Codigo: M-14745-47

Investigador principal: José Carlos Ruiz Carrascosa

 

ENSAYOS CLINICOS ACTIVOS

 

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov Identifier: NCT03569293

Co-investigadores: Ricardo Ruiz Villaverde

Carácter: Europeo

Laboratorio responsable: Abbvie SA

Investigador principal Local: Jose C Ruiz Carrascosa

Iniciado en 2019, en curso

 

A randomized double-blind placebo-controlled study evaluating the effect of dupilumab on sleep in adult patients with moderate to severe atopic dermatitis

Product Code: SAR231893

Dupilumab Study Code / Name: LPS15497

Co-investigadores: Jose Carlos Ruiz Carrascosa

Carácter: Europeo

Laboratorio responsable: Sanofi

Investigador principal Local: Ricardo Ruiz Villaverde

Iniciado en 2020 y completado

 

Estudio fase 4 de comparación y eficacia y seguridad de Brodalumab versus guselkumab en sujetos adultos con psoriasis en placas de moderada a grave y respuesta inadecuada a ustekinumab. Estudio cobra.*

EudraCT: LP0160—510

Investigador principal: Jose Carlos Ruiz Carrascosa

Nº centro: ESP1493

Iniciado en 2021

 

‘An international, multicentre, open label, interventional phase IV clinical study to investigate the efficacy and safety of tildrakizumab 100 mg in patients with moderate-to-severe chronic plaque psoriasis and its impact on their quality of life’.

Código del protocolo: M-14745-42 /EudraCT: 2019-002804-42

Promotor: Almirall

Investigador principal: Jose Carlos Ruiz Carrascosa

Iniciado en 2020 y completado

 

Psoriasis Longitudinal Assessment and Registry (PSOLAR). Registry C0168Z03. A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics

Código del protocolo: ClinicalTrials.gov Identifier: NCT00508547

Promotor: Janssen Scientific Affairs, LLC

Investigador principal: Jose Carlos Ruiz Carrascosa

Iniciado en 2020

 

A Phase 4, Interventional, Randomized, Double-Blind, PlaceboControlled, Multi-National, Study Evaluating the Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Patients With Moderate to Severe Plaque Psoriasis.

Protocol Number: CNTO1959PSO4015

Promotor: Janssen-Cilag International NV

Investigador Principal: Ricardo Ruiz-Villaverde

Iniciado en 2021

 

Última Actualización de la Página: 22/06/2026 16:39:09